Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-M
| Image |  |
|---|---|
| Description | scientific article published on 29 March 2014 |
| Author/s |
author: Sergio Amadori Marco Vignetti |
| Publication date | March 29, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |